New device aims to stop aneurysm growth without open surgery

NCT ID NCT05133492

Ongoing Disease control Sponsor: Nectero Medical, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called the Nectero EAST System in 46 people with abdominal aortic aneurysms (AAA). The goal is to see if it is safe and can stop the aneurysm from growing, reducing the need for major surgery. Participants receive the device through a catheter, and doctors monitor their aneurysm size over 36 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL AORTIC ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal aortic aneurysm Aneurysm triple-A syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AAA ABDOMINAL AORTIC ANEURYSM DILATION AORTA

Contacts and locations

Show contact details

Locations

Auckland City Hospital

Auckland, New Zealand
Pablo Tabon Uribe Hospital

Medellín, Antioquia, Colombia
Pauls Stradins Clinical University Hospital

Riga, Latvia
Prince of Wales Private Hospital

Randwick, New South Wales, 2031, Australia
Queen Mary Hospital

Hong Kong, Southern District, China